Comparison between Aelea Commodities IPO and Nephro Care IPO.
Aelea Commodities IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Nephro Care IPO is a SME Bookbuilding proposed to list at NSE SME.
| Aelea Commodities IPO | Nephro Care IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Ekadrisht Capital Pvt.Ltd. | Corporate Capitalventures Pvt.Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | SS Corporate Securities Ltd. | SS Corporate Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aelea Commodities IPO is up to ₹48.45 Cr whereas the issue size of the Nephro Care IPO is up to ₹39.18 Cr. The final issue price of Aelea Commodities IPO is ₹95.00 per share and of Nephro Care IPO is ₹90.00 per share.
| Aelea Commodities IPO | Nephro Care IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹91.00 per share | ₹85.00 per share |
| Issue Price (Upper) | ₹95.00 per share | ₹90.00 per share |
| Issue Price (Final) | ₹95.00 per share | ₹90.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1200 shares | 1600 shares |
| Fresh Issue Size | 51,00,000 shares | 43,53,600 shares |
| Fresh Issue Size (Amount) | up to ₹48.45 Cr | up to ₹39.18 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 51,00,000 shares | 43,53,600 shares |
| Issue Size Total (Amount) | up to ₹48.45 Cr | up to ₹39.18 Cr |
Aelea Commodities IPO opens on Jul 12, 2024, while Nephro Care IPO opens on Jun 28, 2024. The closing date of Aelea Commodities IPO and Nephro Care IPO is Jul 16, 2024, and Jul 02, 2024, respectively.
| Aelea Commodities IPO | Nephro Care IPO | |
|---|---|---|
| Anchor Bid Date | Jul 11, 2024 | Jun 27, 2024 |
| Issue Open | Jul 12, 2024 | Jun 28, 2024 |
| Issue Close | Jul 16, 2024 | Jul 02, 2024 |
| Basis Of Allotment (Tentative) | Jul 18, 2024 | Jul 03, 2024 |
| Initiation of Refunds (Tentative) | Jul 19, 2024 | Jul 04, 2024 |
| Credit of Share (Tentative) | Jul 19, 2024 | Jul 04, 2024 |
| Listing date (Tentative) | Jul 22, 2024 | Jul 05, 2024 |
| Anchor Lockin End date 1 | Aug 17, 2024 | Aug 02, 2024 |
| Anchor Lockin End date 2 | Oct 16, 2024 | Oct 01, 2024 |
Aelea Commodities IPO P/E ratio is 11.62, as compared to Nephro Care IPO P/E ratio of 55.15.
| Aelea Commodities IPO | Nephro Care IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 86.45 | 85.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 63.66 | 61.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.62 | 55.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹193.03 Cr. | ₹148.38 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 5.92% | 41.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 5.72% | 36.56% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.18 | ₹1.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 5.75% | 24.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aelea Commodities IPO Retail Individual Investors (RII) are offered 17,85,600 shares while in Nephro Care IPO retail investors are offered 17,85,600 shares. Qualified Institutional Buyers (QIB) are offered 10,20,000 shares in Aelea Commodities IPO and 8,25,600 shares in Nephro Care IPO.
| Aelea Commodities IPO | Nephro Care IPO | |
|---|---|---|
| Anchor Investor Reservation | 15,28,800 shares | 12,38,400 shares |
| Market Maker Reservation | 2,68,800 shares | 2,30,400 shares |
| QIB | 10,20,000 shares | 8,25,600 shares |
| NII | 7,65,600 shares | 6,19,200 shares |
| RII | 17,85,600 shares | 14,44,800 shares |
| Employee | 2,25,600 shares | |
| Others | ||
| Total | 51,00,000 shares | 43,53,600 shares |
Aelea Commodities IPO subscribed 195.83x in total, whereas Nephro Care IPO subscribed 715.78x.
| Aelea Commodities IPO | Nephro Care IPO | |
|---|---|---|
| QIB (times) | 104.22x | 245.14x |
| NII (times) | 389.87x | 1,787.19x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 164.95x | 634.12x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 195.83x | 715.78x |
